0B68 Sifri, Randa D - Thomas Jefferson University - Thomas Jefferson University
Randa D. Sifri, MD

Randa D. Sifri, MD

Contact Dr. Sifri

833 Chestnut Street
Suite 301
Philadelphia, PA 19107

(215) 955-2354
(215) 923-9186 fax

Most Recent Peer-reviewed Publications

  1. The increasing incidence of young-onset colorectal cancer: A call to action
  2. Cost-effectiveness of a standard intervention versus a navigated intervention on colorectal cancer screening use in primary care
  3. Colorectal Cancer Screening in the Framework of the Medical Home Model: Findings From Focus Groups and Interviews
  4. A randomized controlled trial of a tailored navigation and a standard intervention in colorectal cancer screening
  5. Variation in Colorectal Cancer Screening Steps in Primary Care: Basis for Practice Improvement
  6. Weight status and perception of colorectal cancer risk
  7. Race and response to colon cancer screening interventions
  8. A randomized trial of genetic and environmental risk assessment (GERA) for colorectal cancer risk in primary care: Trial design and baseline findings
  9. Race/ethnicity, gender, weight status, and colorectal cancer screening
  10. Factors associated with colorectal cancer screening decision stage
  11. Reflections of medical students regarding the care of geriatric patients in the continuing care retirement community
  12. Developing a quality screening colonoscopy referral system in primary care practice: A report from the national colorectal cancer roundtable
  13. Tailored navigation in colorectal cancer screening.
  14. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use
  15. The home visit experience: A medical student's perspective
  16. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening
  17. Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: A pilot study
  18. Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women
  19. Identifying and testing for hereditary susceptibility to common cancers
  20. Use of cancer susceptibility testing among primary care physicians
0